2024-01-012024-12-312024-12-31false10993913INTEGRATED MEDICAL CENTRE UK LTD2025-07-10falseiso4217:GBPxbrli:pure109939132023-12-31109939132024-12-31109939132024-01-012024-12-31109939132022-12-31109939132023-12-31109939132023-01-012023-12-3110993913bus:SmallEntities2024-01-012024-12-3110993913bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3110993913bus:FullAccounts2024-01-012024-12-3110993913bus:PrivateLimitedCompanyLtd2024-01-012024-12-3110993913core:WithinOneYear2024-12-3110993913core:AfterOneYear2024-12-3110993913core:WithinOneYear2023-12-3110993913core:AfterOneYear2023-12-311099391312024-01-012024-12-3110993913core:ShareCapital2024-12-3110993913core:SharePremium2024-12-3110993913core:RevaluationReserve2024-12-3110993913core:OtherReservesSubtotal2024-12-3110993913core:RetainedEarningsAccumulatedLosses2024-12-3110993913core:ShareCapital2023-12-3110993913core:SharePremium2023-12-3110993913core:RevaluationReserve2023-12-3110993913core:OtherReservesSubtotal2023-12-3110993913core:RetainedEarningsAccumulatedLosses2023-12-3110993913core:LandBuildings2024-12-3110993913core:PlantMachinery2024-12-3110993913core:Vehicles2024-12-3110993913core:FurnitureFittings2024-12-3110993913core:OfficeEquipment2024-12-3110993913core:NetGoodwill2024-12-3110993913core:IntangibleAssetsOtherThanGoodwill2024-12-3110993913core:ListedExchangeTraded2024-12-3110993913core:UnlistedNon-exchangeTraded2024-12-3110993913core:LandBuildings2023-12-3110993913core:PlantMachinery2023-12-3110993913core:Vehicles2023-12-3110993913core:FurnitureFittings2023-12-3110993913core:OfficeEquipment2023-12-3110993913core:NetGoodwill2023-12-3110993913core:IntangibleAssetsOtherThanGoodwill2023-12-3110993913core:ListedExchangeTraded2023-12-3110993913core:UnlistedNon-exchangeTraded2023-12-3110993913core:LandBuildings2024-01-012024-12-3110993913core:PlantMachinery2024-01-012024-12-3110993913core:Vehicles2024-01-012024-12-3110993913core:FurnitureFittings2024-01-012024-12-3110993913core:OfficeEquipment2024-01-012024-12-3110993913core:NetGoodwill2024-01-012024-12-3110993913core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110993913core:ListedExchangeTraded2024-01-012024-12-3110993913core:UnlistedNon-exchangeTraded2024-01-012024-12-3110993913core:MoreThanFiveYears2024-01-012024-12-3110993913core:Non-currentFinancialInstruments2024-12-3110993913core:Non-currentFinancialInstruments2023-12-3110993913dpl:CostSales2024-01-012024-12-3110993913dpl:DistributionCosts2024-01-012024-12-3110993913core:LandBuildings2024-01-012024-12-3110993913core:PlantMachinery2024-01-012024-12-3110993913core:Vehicles2024-01-012024-12-3110993913core:FurnitureFittings2024-01-012024-12-3110993913core:OfficeEquipment2024-01-012024-12-3110993913dpl:AdministrativeExpenses2024-01-012024-12-3110993913core:NetGoodwill2024-01-012024-12-3110993913core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110993913dpl:GroupUndertakings2024-01-012024-12-3110993913dpl:ParticipatingInterests2024-01-012024-12-3110993913dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3110993913core:ListedExchangeTraded2024-01-012024-12-3110993913dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3110993913core:UnlistedNon-exchangeTraded2024-01-012024-12-3110993913dpl:CostSales2023-01-012023-12-3110993913dpl:DistributionCosts2023-01-012023-12-3110993913core:LandBuildings2023-01-012023-12-3110993913core:PlantMachinery2023-01-012023-12-3110993913core:Vehicles2023-01-012023-12-3110993913core:FurnitureFittings2023-01-012023-12-3110993913core:OfficeEquipment2023-01-012023-12-3110993913dpl:AdministrativeExpenses2023-01-012023-12-3110993913core:NetGoodwill2023-01-012023-12-3110993913core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3110993913dpl:GroupUndertakings2023-01-012023-12-3110993913dpl:ParticipatingInterests2023-01-012023-12-3110993913dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3110993913core:ListedExchangeTraded2023-01-012023-12-3110993913dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3110993913core:UnlistedNon-exchangeTraded2023-01-012023-12-3110993913core:NetGoodwill2024-12-3110993913core:IntangibleAssetsOtherThanGoodwill2024-12-3110993913core:LandBuildings2024-12-3110993913core:PlantMachinery2024-12-3110993913core:Vehicles2024-12-3110993913core:FurnitureFittings2024-12-3110993913core:OfficeEquipment2024-12-3110993913core:AfterOneYear2024-12-3110993913core:WithinOneYear2024-12-3110993913core:ListedExchangeTraded2024-12-3110993913core:UnlistedNon-exchangeTraded2024-12-3110993913core:ShareCapital2024-12-3110993913core:SharePremium2024-12-3110993913core:RevaluationReserve2024-12-3110993913core:OtherReservesSubtotal2024-12-3110993913core:RetainedEarningsAccumulatedLosses2024-12-3110993913core:NetGoodwill2023-12-3110993913core:IntangibleAssetsOtherThanGoodwill2023-12-3110993913core:LandBuildings2023-12-3110993913core:PlantMachinery2023-12-3110993913core:Vehicles2023-12-3110993913core:FurnitureFittings2023-12-3110993913core:OfficeEquipment2023-12-3110993913core:AfterOneYear2023-12-3110993913core:WithinOneYear2023-12-3110993913core:ListedExchangeTraded2023-12-3110993913core:UnlistedNon-exchangeTraded2023-12-3110993913core:ShareCapital2023-12-3110993913core:SharePremium2023-12-3110993913core:RevaluationReserve2023-12-3110993913core:OtherReservesSubtotal2023-12-3110993913core:RetainedEarningsAccumulatedLosses2023-12-3110993913core:NetGoodwill2022-12-3110993913core:IntangibleAssetsOtherThanGoodwill2022-12-3110993913core:LandBuildings2022-12-3110993913core:PlantMachinery2022-12-3110993913core:Vehicles2022-12-3110993913core:FurnitureFittings2022-12-3110993913core:OfficeEquipment2022-12-3110993913core:AfterOneYear2022-12-3110993913core:WithinOneYear2022-12-3110993913core:ListedExchangeTraded2022-12-3110993913core:UnlistedNon-exchangeTraded2022-12-3110993913core:ShareCapital2022-12-3110993913core:SharePremium2022-12-3110993913core:RevaluationReserve2022-12-3110993913core:OtherReservesSubtotal2022-12-3110993913core:RetainedEarningsAccumulatedLosses2022-12-3110993913core:AfterOneYear2024-01-012024-12-3110993913core:WithinOneYear2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110993913core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3110993913core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3110993913core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3110993913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3110993913core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3110993913core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3110993913core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3110993913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3110993913core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3110993913core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3110993913core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3110993913core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3110993913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3110993913core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3110993913core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3110993913core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3110993913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3110993913core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3110993913bus:Director12024-01-012024-12-3110993913bus:Director22024-01-012024-12-3110993913core:FurnitureFittingsToolsEquipment2023-12-3110993913core:FurnitureFittingsToolsEquipment2024-12-3110993913core:FurnitureFittingsToolsEquipment2024-01-012024-12-31

INTEGRATED MEDICAL CENTRE UK LTD

(formerly LONDON REHABILITATION CENTRE LIMITED)

Registered Number
10993913
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

INTEGRATED MEDICAL CENTRE UK LTD
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

I Ali
Mrs S Ali

Registered Address

121 Crawford Street
London
W1U 6BE

Registered Number

10993913 (England and Wales)
INTEGRATED MEDICAL CENTRE UK LTD
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3141,189167,177
141,189167,177
Current assets
Debtors4258,489129,914
Cash at bank and on hand33971,188
258,828201,102
Creditors amounts falling due within one year5(267,223)(321,528)
Net current assets (liabilities)(8,395)(120,426)
Total assets less current liabilities132,79446,751
Creditors amounts falling due after one year6-(29,925)
Net assets132,79416,826
Capital and reserves
Called up share capital100100
Profit and loss account132,69416,726
Shareholders' funds132,79416,826
The financial statements were approved and authorised for issue by the Board of Directors on 10 July 2025, and are signed on its behalf by:
I Ali
Director
Registered Company No. 10993913
INTEGRATED MEDICAL CENTRE UK LTD
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes for the Osteopath services provided and is recognised.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are initially stated at cost and subsequently stated at cost less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Land and buildings-5
Plant and machinery25-
Fixtures and fittings25-
Office Equipment25-
Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Basic financial liabilities Basic financial liabilities, including creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20242023
Average number of employees during the year65
3.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 January 24157,54516,4105219,190183,666
At 31 December 24157,54516,4105219,190183,666
Depreciation and impairment
At 01 January 24-10,997-5,49216,489
Charge for year23,6321,3547892425,988
At 31 December 2423,63212,351786,41642,477
Net book value
At 31 December 24133,9134,0594432,774141,189
At 31 December 23157,5455,4135213,698167,177
4.Debtors: amounts due within one year

2024

2023

££
Amounts owed by group undertakings258,389129,814
Other debtors100100
Total258,489129,914
5.Creditors: amounts due within one year

2024

2023

££
Bank borrowings and overdrafts-6,028
Taxation and social security49,70622,258
Other creditors55,323132,409
Accrued liabilities and deferred income162,194160,833
Total267,223321,528
6.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts-29,925
Total-29,925
7.Operating lease commitments
Minimum lease payments under non-cancellable operating leases fall due as follows: Due within one year: £72,000 (2023: £72,000)
8.Related party transactions
Included in other creditors due with in one year at the year end is an amount of £36,155 (2023: £130,436) due to the directors. During the year, company paid £72,000 (2023: Nil) as rent to the group company Ali & Sons Estates Limited. Controlling Party: The company's immediate parent company is Ali & Sons Estates Ltd and it's ultimate parent company is Yar Ambia Limited whose registered office address is :121 Crawford Street, London, United Kingdom, W1U 6BE